Cover Image

Efficacy and safety of glucocorticoid combined with cyclophosphamide therapy on membranous nephropathy: a systematic review and meta-analysis

BackgroundThis review systematically evaluates the efficacy and safety of the combined treatment of glucocorticoids (GC) and cyclophosphamide (CTX) in patients with membranous nephropathy (MN).MethodsAs of June 2024, a comprehensive literature search was performed utilizing several reputable databas...

Full description

Saved in:

Bibliographic Details
Main Authors:	Chengcheng Feng (Author), Xuexun Chen (Author), Xiangming Wang (Author), Min Guo (Author), Zhentao Guo (Author)
Format:	Book
Published:	Frontiers Media S.A., 2024-11-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Efficacy and safety of tacrolimus vs cyclophosphamide in the therapy of patients with idiopathic membranous nephropathy: a meta-analysis
by: Lin W, et al.
Published: (2019)

Efficacy and safety of rituximab in elderly patients with membranous nephropathy
by: Yanhong Guo, et al.
Published: (2023)

Newer Concepts In Intravenous Glucocorticoid And Cyclophosphamide Pulse Therapy In Dermatology
by: Thappa Devinder Mohan, et al.
Published: (2003)

The Efficacy of Cyclophosphamide Combined with Prednisone in Membranous Nephropathy Patients with Different Cytochrome P450 2B6 Gene Polymorphisms and Analysis of Factors Influencing the Efficacy
by: Zhang M, et al.
Published: (2022)

Treatment of Membranous Nephropathy in Chinese Patients: Comparison of Rituximab and Intravenous Cyclophosphamide with Steroids
by: Xiaofan Hu, et al.
Published: (2024)

Effects of CYP3A5 Polymorphisms on Efficacy and Safety of Tacrolimus Therapy in Patients with Idiopathic Membranous Nephropathy
by: Zhang C, et al.
Published: (2020)

Efficacy and safety of Chinese herbal medicines combined with biomedicine in the treatment of idiopathic membranous nephropathy: a systematic review and network meta-analysis
by: He Zhu, et al.
Published: (2024)

Efficacy and safety of two dose regimens of rituximab for idiopathic membranous nephropathy
by: Zhi-hui Tu, et al.
Published: (2024)

Mycophenolate mofetil versus cyclophosphamide for idiopathic membranous nephropathy; a double blind and randomized clinical trial
by: Fatemeh Hayati, et al.
Published: (2019)

Efficacy and safety of Tripterygium wilfordii multiglucoside for idiopathic membranous nephropathy: a systematic review with bayesian meta-analysis
by: Hongyun Wang, et al.
Published: (2023)

Efficacy and safety of 12 immunosuppressive agents for idiopathic membranous nephropathy in adults: A pairwise and network meta-analysis
by: Jiarong Liu, et al.
Published: (2022)

Evaluating Efficacy and Safety of Tacrolimus Treatment in Membranous Nephropathy: Results of a Retrospective Study of 182 Patients
by: Liang S, et al.
Published: (2023)

Risk factors of new-onset glucose abnormalities in idiopathic membranous nephropathy patients on glucocorticoid plus tacrolimus
by: Jin Li, et al.
Published: (2023)

Efficacy and safety of cyclosporine A in the treatment of idiopathic membranous nephropathy in an Asian population
by: Lin S, et al.
Published: (2019)

Efficacy and Safety of Different Immunosuppressive Therapies in Patients With Membranous Nephropathy and High PLA2R Antibody Titer
by: Le Deng, et al.
Published: (2022)

IgA nephropathy combined with thin basement membrane nephropathy in children
Published: (2013)

Clinical manifestations of IgA nephropathy combined with thin glomerular basement membrane nephropathy in children
by: Young Ju Hwang, et al.
Published: (2013)

Efficacy and safety of a modified- 'modified Ponticelli' regimen for treatment of primary membranous nephropathy
by: Indu Ramachandra Rao, et al.
Published: (2019)

Effect of corticosteroids combined with cyclophosphamide or mycophenolate mofetil therapy for IgA nephropathy with stage 3 or 4 chronic kidney disease: A retrospective cohort study
by: Qing Jia, et al.
Published: (2022)

Efficacy/Safety of the Use of Glucocorticoids in Oral and Maxillofacial Surgery
by: Heilyn Joanna Nils, et al.
Published: (2023)

Comparative Efficacy and Safety of Chinese Herbal Injections Combined With Cyclophosphamide and 5-Fluorouracil Chemotherapies in Treatment of Breast Cancer: A Bayesian Network Meta-Analysis
by: Shuyu Liu, et al.
Published: (2021)

The Efficacy and Safety of Bivalirudin Versus Heparin in the Anticoagulation Therapy of Extracorporeal Membrane Oxygenation: A Systematic Review and Meta-Analysis
by: Min Ma, et al.
Published: (2022)

Efficacy and Safety of Immunosuppressive Monotherapy Agents for IgA Nephropathy: A Network Meta-Analysis
by: Shisheng Han, et al.
Published: (2021)

Efficacy and safety of Chinese herbal medicines combined with cyclophosphamide for connective tissue disease-associated interstitial lung disease: A meta-analysis of randomized controlled trials
by: Xietian Yin, et al.
Published: (2023)

Efficacy and safety of zoledronic acid in the treatment of glucocorticoid-induced osteoporosis
by: Ege Can Serefoglu, et al.
Published: (2010)

Efficacy and Safety of Agents in IgA Nephropathy: An Update Network Meta-Analysis
by: Pingping Yang, et al.
Published: (2018)

Immunosuppressive therapy for progressive idiopathic membranous nephropathy: a cost-effectiveness analysis in China
by: Wanyi Xu, et al.
Published: (2023)

Efficacy and safety of Abelmoschus moschatus capsules combined with tripterygium glycoside tablets on diabetic nephropathy: A systematic review and meta-analysis
by: Peipei Zhou, et al.
Published: (2022)

Rituximab in patients with membranous nephropathy and kidney insufficiency
by: Yanhong Guo, et al.
Published: (2022)

Comparison of the efficacy of steroid-free versus classic steroid-containing regimens in primary membranous nephropathy
by: Hui-Lin Xing, et al.
Published: (2024)

Efficacy of tacrolimus plus glucocorticoid for lupus nephritis: a Meta-analysis
by: Yi-xi Xing, et al.
Published: (2024)

Overproduction of Mitochondrial Fission Proteins in Membranous Nephropathy in Children
by: Qi-Jiao Wei, et al.
Published: (2018)

Educational Case: Membranous Nephropathy
by: Christina C. Smith MS, et al.
Published: (2018)

Research advances of factors and mechanisms for therapeutic efficacy of rituximab for primary membranous nephropathy
by: Yu-ting Liu, et al.
Published: (2024)

Efficacy and Safety of Combined Vitrectomy with Intravitreal Dexamethasone Implant for Advanced Stage Epiretinal Membrane
by: Iovino C, et al.
Published: (2019)

Efficacy and safety of traditional Chinese medicine decoction as an adjuvant treatment for diabetic nephropathy: a systematic review and meta-analysis of randomized controlled trials
by: Shuyu Zheng, et al.
Published: (2024)

Safety and tolerability of high doses of glucocorticoides
by: Rakić Branislava D., et al.
Published: (2016)

The efficacy and safety of Sanqi Qushi Granule in patients with idiopathic membranous nephropathy --protocol of a multicenter, randomized control trial (SQ-AUTUMN)
by: Chuang Li, et al.
Published: (2023)

Effectiveness and safety of leflunomide compared with cyclophosphamide as induction therapy in Takayasu's arteritis: an observational study
by: Xiaomin Dai, et al.
Published: (2020)

Clinical features and short-term outcomes of patients with membranous nephropathy complicated with COVID-19
by: Kai-qi Guo, et al.
Published: (2023)